Cohort of Patients With Chronic Myelomonocytic Leukemia

Cohort of Patients With Chronic Myelomonocytic Leukemia

A prospective, non-interventional study involving the collection of biological samples with associated anonymised data.

Biological samples will be collected at the time of diagnosis and/or as the disease progresses, with or without treatment, always in conjunction with tests scheduled as part of routine care or within the context of a clinical trial.

Inclusion Criteria:

• Adults aged 18 years and over
• Blood monocytosis ≥ 0.5 × 10⁹/L and ≥ 10% of total white blood cells or
• Confirmed diagnosis of chronic myelomonocytic leukemia
• Regardless of stage (chronic or transformed), and whether or not currently being treated
• Signed informed consent

Exclusion Criteria:

• Active, uncontrolled infection (particularly hepatitis B, hepatitis C, HIV)
• Refusal informed consent